Clearmind Medicine Inc. (CMND) Stock Ticker
Market factors today
Unlock the full CMND picture
About Clearmind Medicine Inc.
Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments. Their primary goal is to address a variety of mental health and addiction challenges that currently lack adequate solutions. The company's research targets conditions such as alcohol use disorder (including problematic binge drinking), various eating disorders (like binge eating), depression, and other compulsive or "binge" behaviors. Founded in 2017, the company initially operated under the name Cyntar Ventures Inc. before officially rebranding as Clearmind Medicine Inc. in March 2021. Its operations are headquartered in Vancouver, Canada.
CMND stock facts
| Ticker symbol | CMND |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.2M |
| CEO | Adi Zuloff-Shani |
| Employees | 4 |
| Headquarters | Vancouver, BC, CA |
| IPO date | 2022-11-15 |
| Website | www.clearmindmedicine.com |
What you can see for CMND on Tickr
Live CMND price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CMND report.
Rankings
FAQ
What is the ticker symbol for Clearmind Medicine Inc.?
The ticker symbol for Clearmind Medicine Inc. is CMND, listed on the NASDAQ Capital Market.
What is CMND?
Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments. Their primary goal is to address a variety of mental health and addiction challenges that currently lack adequate solutions. The company's research targets conditions such as alcohol use disorder (including problematic binge drinking), various eating…